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Abstract 
 
 Multifunctional nanomedicine holds considerable promise as the next generation of 
medicine that allows for targeted therapy with minimal toxicity. To evaluate the delivery 
efficiency of Nanoparticles (NPs), it is important to study their transport, binding and 
distribution in blood flow. For blood flow in capillaries, arterioles and venules, the 
particulate nature of the blood and physiological conditions needs to be considered in the 
delivery process. The existence of the cell-free-layer, NP-cell interaction, particle shape 
and vessel geometry will largely influence the dispersion, binding rates and distribution, 
thus impact targeted delivery efficacy. In this thesis, a particle-cell hybrid model is 
developed to model NP transport, dispersion, and binding dynamics in blood suspension. 
The motion and deformation of red blood cells is captured through the Immersed Finite 
Element Method. The motion and adhesion of individual NPs are tracked through 
Brownian adhesion dynamics. The influence of red blood cells, vascular flow rate, 
particle size, shape and vessel geometry effect on NP distribution and delivery efficacy is 
characterized. With red blood cells, a non-uniform NP distribution profile with higher 
particle concentration near the vessel wall is observed, which leads to over 50% higher 
particle binding rate compared to the case without red blood cell. The tumbling motion of 
red blood cells in the core region of the capillary is found to enhance NP dispersion, and 
dispersion rate increases with shear rate. The simulation results also indicate that NPs 
with smaller size and rod shape have higher binding rates. The binding dynamics of rod-
shaped NPs is found to be dependent on their initial contact points and orientations to the 
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wall. Moreover, it is found that Péclet number plays an important role in determining the 
fraction of NPs deposited in the branched region and the straight section. Simulation 
results also indicate that NP binding rate decreases with increased shear rate. Dynamic 
NP re-distribution from low to high shear rates is observed due to the non-uniform shear 
stress distribution over the branched channel. Results from this study contribute to the 
fundamental understanding and knowledge on how the particulate nature of blood, size, 
shape and vessel geometry influences NP delivery and distribution, which will provide 
mechanistic insights on the nanomedicine design for targeted drug delivery applications. 
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Chapter 1. Introduction 
1.1 Nanoparticle based drug delivery 
 Over the past decades, various nanoplatforms, including liposomes[1-2], 
polymeric micelles[3-6], quantum dots[7-8], Au/Si/polymer shells[9-11], dentrimers[12-
14], and Nanoparticles[15] have been emerged and developed as smart drug carriers and 
image probing agents. Many unique properties and potential applications offered by NPs 
attract the attentions of scientist, engineers and medical researchers. For example, NPs 
can imbibe drug into their core or coat drug to their surface to fight against 
cardiovascular disease. Their half time in circulation and selectively distribution can be 
modulated by their size and shape which can be achieved easily with advanced 
microfabrication technology. Active and controlled drug release can be triggered by the 
properties of the surrounding environment, such as PH level, light intensity, and 
temperature. Iron oxide NPs can be functionalized with different ligands to target the 
particular receptors expressed on cancer cells. The magnetic properties of the Iron oxide 
enhance the image in magnetic resonance imaging[16-17]. Gold nanocages with large 
absorption cross section per volume can convert light into heat for photothermal 
destruction under the excitation of laser[18]. The research work in this thesis is focused 
on modeling NP transport, binding and distribution under the influence of red blood cells 
and complex vessel geometries. 
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1.2 Properties of engineered nanoparticles  
 Properties such as size, shape, surface chemistry play an important role in NP 
binding and distribution. As a key characteristic of NP, size has been studied extensively 
in literature. For example, it is known that spherical particles bigger than 200 nm are 
efficiently filtered by liver, spleen and bone marrow, while particles smaller than 10 nm 
can be quickly cleared by kidney or through extravasation, thus making 10-200 nm as an 
ideal size range for the circulating spherical carriers. Similar to size, shape is also a 
fundamental property of micro/nanoparticles that is critical for their intended biological 
functions. Most nanoparticles have spherical shape due to surface tension. With the 
advanced nanofabrication techniques, different shapes and forms of NP have emerged in 
recent years with unique geometrical, physical and chemical properties. For example, 
nanorods with suitable aspect ratio have been fabricated as a novel contrast agent for both 
molecular imaging and photothermal cancer therapy[19]; asymmetrically functionalized 
AuNPs have been assembled to build nanochains[20]; superparamagnetic iron oxide 
based nanoworms are studied for tumor targeting[21], and nanonecklaces are assembled 
using gold nanoparticles by covalent bonding[22]. It has been reported that cylindrically 
shaped filamicelles can effectively evade non-specific uptake by the Reticulo-Endothelial 
System, allowing persistent circulation for up to one week after intravenous injection[23]. 
Besides size and shape, surface functionalization of nanoparticle determines the adhesion 
capability of NPs. For nanorods, it is reported that Janus coating at the two ends of 
nanorods leads to better adhesion compared to uniform coating[24-25]. Protein 
adsorption and phagocytosis of particles in vivo has been shown to be reduced by the 
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immobilization of polyethylene glycol (PEG) on them[26]. Many studies apply PEG 
based copolymer modification which enhances circulating half-life while contributing to 
decreased uptake in nontargeted cells. On the other hand, phage display based targeting 
on various organs has been performed by the immobilization of peptides on them. 
Selective localization of bacteriophage to brain and kidney blood vessels were performed 
by applying peptides capable of targeting and showed up to 13-fold selectivity for these 
organs[27].  
1.3 Motivations to model nanoparticle transport 
 Although NPs offer many advantages over conventional drug carriers, their 
transport, binding and distribution are not fully understood. First, NPs are too small to be 
visualized in vivo with dimensions between ten to a few hundred nanometers; it is 
challenging to track NP trajectories in vivo. Second, biological environment in vivo for 
NP is very complex, which involves blood flow, circulation, elimination and 
extravasation. NPs cannot always reach targeted site because they may be filtered by liver, 
eliminated by spleen, bonded to healthy cells. 
 To achieve better delivery efficacy, the diseased region type, size, location, and 
the patient’s physical parameters (e.g. vascular diameter, blood flow rate, surface area, 
blood components) need to be considered. The NP targeted delivery in vascular system 
involves interplay of transport, hydrodynamic force, and multivalent interactions with 
targeted biosurfaces. It is very challenging to explore these phenomena experimentally in 
vivo, due to the small size of NPs, the dynamic delivery process, and the complex 
vascular environment. Thus a mathematical tool that can predict and evaluate the NP 
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binding and distribution is necessary. At microscale, current theoretical works of NP 
deposition are limited to simple spherical particles under an ideal condition in a 2D 
channel under shear flow[28-30], which cannot predict the behaviors of particles of 
various designs in blood flow under complex vascular conditions. At macroscale, 
continuum convection-diffusion-reaction models have been widely used in modeling 
drug delivery process. For example, Shipley et al.[31] and Modok et al.[32] modeled 
delivery of spherical NPs in tumor. Mahmoudi et al.[33] and Li et al.[34] performed 
computational fluid dynamics studies of magnetic NPs in vascular flow. Liu et al.[35] 
and Zhang et al.[36] studied the deposition of NPs in lung airway. However, continuum 
model cannot provide details such size, shape, ligand-receptor density, and shear 
dependent effect on NP binding. 
 Another concern is that little is known about NP binding and distribution under 
the influence of red blood cells (RBCs) and in different vascular geometries. When blood 
flows through vessels, the two-phase nature of the blood becomes important as the 
diameter of RBCs becomes comparable to the vessel diameter. Various unique 
phenomena have been observed in microcirculation due to the particulate nature of the 
blood, such as (a) vessel diameter dependent apparent viscosity: Fåhraeus–Lindqvist 
effect; (b) existence of a cell-depleted layer near the wall: cell free layer; and (c) blunt 
velocity profile. These phenomena have significant impact on NP targeted delivery 
efficiency. First, targeted binding to diseased cells requires NPs to move close to the 
vascular wall, i.e, in a near wall binding-layer. Such a near wall binding-layer is 
coincident with the cell-free layer, with the addition of NPs in such layer. However, the 
thickness of such cell-free layer varies with vascular conditions, thus changes the binding 
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properties. Second, the existence of blood cells in the core region of blood streams 
changes the NP dispersion rate through cell-NP interaction. Many blood vessels consist 
the whole vascular network. It is reported experimentally NPs have different binding 
preference in microvascular network[37], i.e., more particles bonded to the bifurcation 
region than the straight section of the channel. With these in mind, it is natural to ask: 
What is the effect of RBCs on NP delivery? Is NP binding vessel geometry dependent? 
What controls NP distribution pattern in branched vessels? Thus, it is crucial to 
characterize NP transport with RBCs and under different vascular flow conditions 
through a mathematical model[38]. 
This thesis attempts to answer these questions through numerical simulations. A 
combined continuum fluid model and Brownian adhesion dynamics model is developed 
to simulate NP transport in blood flow. The thesis is organized as follows. Chapter 1 
introduces the background of NP delivery and the motivation of this study. Chapter 2 
discusses the methods used to simulate particle motion and fluid flow. Chapter 3 gives 
detailed simulation process and results of the NP delivery with RBCs considered. Chapter 
4 presents NP distribution in a simplified branched vessel. Lastly, the future work is 
described in Chapter 5. 
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Chapter 2. Numerical Methods for Nanoparticle Delivery in 
Blood Flow 
 In this chapter, techniques used to model NP transport and diffusion will be 
introduced first. The model of red blood cells and finite element based computational 
fluid methods are described next. Finally, the interaction potentials between NPs, NP-
RBCs are presented. 
2.1 Nanoparticle Brownian dynamics 
 Brownian motion theory points out that small particles immersed in fluids are 
subjected to the random collisions from the surrounding liquid molecules[39-41]. 
Patankar et al.[42] proposed an algorithm for direct numerical simulation of Brownian 
motion by adding random disturbance in fluids. At microscale, the Brownian motion is 
negligible compared to larger drag forces (> 50 pN for particle size > 1 µm)[43]. At 
nanoscale, Brownian force outweighs the drag force, becoming a dominant force to drive 
NP near vessel wall. The random forces R(t) and random Torques T(t) acting on a NP are 
responsible for Brownian motion and satisfy the fluctuation-dissipation theorem[44]: 
 ( ) 0, ( ) 0i it t= =R  T ,    (1)  
 
( ) ( ') 2 ( ')
( ) ( ') 2 ( ')
i j B t ij
i j B r ij
t t k T t t
t t k T t t
β δ δ
β δ δ
= −
= −
R R δ
T T δ
, 
(2)  
(3)  
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where, δ is the unit-second order tensor, δij is the Kronecker delta, δ(t − t′) is the Dirac 
delta function, kBT is thermal energy of system, βt and βr are translational and rotation 
friction coefficient, respectively. 
 The friction coefficient depends on several physical parameters, such as fluid 
viscosity, size and shape of the NP. The friction coefficient for particles can be easily 
derived from Stokes’ law: 
 3
3t
r
d
d
β π µ
β π µ
=
=
  
(4)  
(5)  
 where µ is the fluid viscosity, d is the diameter of particle. The velocity of a 
particle moving under a deterministic force in a fluid with velocity Vf is given by:  
 det det
f f
t
p
rβ β
+
   
×   
  
F T
V = + V + ω r
 
(6)  
 where Vf  and  ωf are fluid translational and angular velocity vectors, respectively; 
Vp is the particle velocity; r is the position vector from the centroid of NPs; Fdet and Tdet 
are the total deterministic force and torque acting on the NP (including Brownian 
force/torque, adhesion force/torque, etc.).  
2.2  Receptor-ligand binding model 
 Receptor and ligand binding process has been studied extensively. Bell 
established the theoretical framework for cell adhesion mediated by reversible bonds[45-
46]. Ward also listed some 'best' values for parameters related to the cell-substrate 
adhesion[47]. Motivated by their work, the receptor-ligand binding process is governed 
by equation: 
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 ( )( )b f l b r b r b
N
k N N N N k N
t
∂
= − − −
∂
 (7)  
 where Nb is the number of formed receptor-ligand pairs; kf is the forward binding 
rate, Nl is the ligand density on the particle surface; Nr is the receptors on the vessel wall; 
kr is bond reverse binding rate. 
 The parameters used in our model are chosen according to physiological values 
reported in literature and are summarized in Table 1 : 
Table 1. Parameters used in the receptor ligand binding model 
Parameters Value reference 
Ligand density Nl 200/µm
2 [47] 
Receptor density Nr 100/µm
2 [47] 
Unstressed bond length L 20 nm [45-46] 
Bond spring constant 0.5 dyn/cm [47] 
Forward binding rate kf 1×10
6 nm2/s [48] 
Reverse binding rate kr 1×10
-2 /s [48] 
 
 According to these parameters, the binding force for a single ligand-receptor bond 
is around 5 pN which is within the range of Bell's estimation 40 pN[45]. In the model, as 
long as adhesive force induced by the total bonds is larger than drag force, the particle is 
assumed to be bonded to the wall. 
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2.3 Red Blood Cell and Fluid-Structure Interaction Model 
      
Figure 1. (A) Geometry and mesh of RBC; (B) Mesh of RBC and fluid 
  
 In the simulation, RBCs are modeled as flexible thin membranes enclosing a fluid 
[49-50], as shown in Figure 1.  Both the cytoplasm inside the RBC and the blood plasma 
outside the RBC have a viscosity of around 0.01 dyn·s/cm, thus are treated as the same 
fluid. A Mooney–Rivlin strain energy function similar to that of our previous work[49-50] 
and others[51-53], is used to depict the material behavior of the RBC membrane: 
 W = C1 ( I1 − 3 ) + C2 ( I2 − 3 )   (8)  
with the material properties specified by constants C1 and C2.  I1 and I2 are the functions 
of the invariants of the Cauchy-Green deformation tensor C.  
 RBCs and their interaction with fluid flow are modeled by the IFEM 
formulation[49-50]. The IFEM was developed by Zhang et al. and Liu et al.[54-57] to 
solve coupled fluid-structure interaction problems.  Because much of the method has 
been derived in detail in works[54-57], we will just briefly list out the IFEM procedures 
below, and refer the interested reader to those for further details.  The fluid in the 
A B 
8µm 
2µ
m
 
3D view 
Cross-section 
view 
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simulation is assumed to be an incompressible viscous fluid governed by the Navier–
Stokes equations:  
 2f
f f f
t
pρ µ
∂ 
+ ∂ 
⋅∇ = −∇ + ∇
v
v v v  (9)  
 0f∇⋅ =v  (10) 
 where 
fv  is the fluid velocity in the fluid domain.  Motivated by Peskin’s 
immersed boundary method[58-60], as in IFEM[57], an extra volumetric force is 
introduced to avoid the complex re-meshing usually encountered in the fluid-structure 
interaction problems. This extra force FSIF , called the fluid-structure interaction force, is 
defined as: 
 
s
FSI
s
s s s ), Ω
Ω \ Ω
( ) ( ) ( in  
0 in  
ffρ ρ +


− − − ∇⋅ −
=
,
v g σ σ
F
&
 (11) 
where v  is the velocity, ρ  is the density and σ  is the Cauchy stress tensor. s and f 
donate for solid and fluid respectively.   
 For a Newtonian fluid of uniform viscosity, fσ  can be written as: 
 
 ( )f f f f Tp µ    = − + ∇ + ∇σ I v v   (12) 
where µ  is the fluid viscosity and fp is the hydrostatic pressure.  
 To interpolate between the Eulerian and Lagrangian domains, a restriction 
operator stL  from Ω  onto Ω
s is needed to make the system complete: 
 0( )( , ) ( ( , ), ),s
t
sL t t tψ ψ
Ω
≡ ∀ ∈ΩX x X X   (13) 
 With this mapping function, we obtain the solid velocity and displacement from 
the Eulerian space as: 
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 s s sin ΩtL= ,v v   (14) 
 s
s
s in Ω
t
∂
= ,
∂
u
v   (15) 
Eqn.(14) basically interpolates the solid velocity from the fluid field through a mapping 
function. 
 The coupled fluid-structure interaction equations are solved through finite 
element method. The weak forms of the immersed system and other details can be found 
in previous publication[57] . To reduce numerical oscillations, the velocity test function 
is employed along with stabilization parameters. Using integration by parts and the 
divergence theorem, the Patrov-Galarkin weak form is obtained. Then, the nonlinear 
system is solved using the Newton-Raphson method. Moreover, Generalized Minimum 
Residual (GMRES) iterative algorithm is employed to improve computation efficiency 
and to compute residuals based on matrix-free techniques[61].  
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Chapter 3. Influence of Red Blood Cells on Nanoparticle 
binding and distribution in microcirculation 
 Blood is a complex biological fluid made of components such as red blood cells 
(RBC), monocytes, platelets, proteins, etc. RBCs occupy about 45% of the blood by 
volume. In this model, RBCs are considered to study their effect on NP transport, 
diffusion and binding. Various potentials are introduced to model particle-particle, and 
cell particle interactions. Different time steps are used to track NP and RBCs motion.  
3.1 Particle-Particle and Particle-Cell Interaction Model  
 
 
Figure 2. (A) 3D simulation of nanoparticle-RBC interaction; (B) Cross-section view of 
nanoparticle-RBC interaction. 
 
 A schematic illustration for Particle-cell interaction is given in Figure 2. The 
motion of NPs is governed by Brownian adhesion dynamics[7]. As described in Chapter 
2, RBCs and their interaction with fluid flow is modeled by IFEM formulation[49-50]. 
Cell free layer 
Train of RBCs 
A B 
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For NPs, a Lennard-Jones potential is introduced to characterize the interaction between 
individual particles.  
 12 6( ) 4 [( ) ( ) ]
σ σ
ε= −V r
r r
  (16) 
 13 7( ) 24( ) [2( ) ( ) ]
ε σ σ
σ
= − = −
dV r
F r
dr r r
  (17) 
where σ is the distance at which the energy is zero, ε is the strength of the potential 
energy. 
 A short-range repulsive Morse potential is used to avoid overlapping between 
NPs and RBCs: 
 0 02 ( ) ( )( ) [ 2 ]β βφ − −= −r r r rer D e e  (18) 
 0 02 ( ) ( )( )( ) 2 [ ]β β
φ
β − −
∂
= − = −
∂
r r r r
e
r
f r D e e
r
  (19) 
where 0r  and eD  stand for the zero force length and surface energy respectively, and β is 
a scaling factor.   Similar cell-particle collision model has been used by Almomani et al. 
[62] to study the erythrocyte-platelet interaction in blood flow, where the collision forces 
were modeled as spring forces between the surfaces of the colliding particles and 
erythrocytes. The parameters used in the simulation model are listed in Table 2. 
Table 2. Parameters used in Lennard-Jones potential and Morse potential 
Parameter ε  σ  eD  β  0r  
Value 10-15 J 200.0 nm 4.1×10-13 J 2 µm-1 0.5 µm 
 
 
 16 
 It should be noticed that different time steps are used to track particle motion and 
blood cell deformation, i.e., a smaller time step dtt for NPs and a larger time step dt for 
blood cell-fluid interaction, as shown in Figure 3A and 3B.  The time steps are 
determined by the flow velocity and the particle diffusion speed. A small time step is 
needed to capture the high speed Brownian motion while a larger time step can be used 
for relatively slow RBC-fluid interaction. Similar different time steps had been used to 
capture the many-particle binding dynamics with a receptor coated surface by Arieh et 
al.[63].  
 
Figure 3. Illustration of the two time steps and mapping algorithms used in the simulation. 
(A) Overlapping happens when the same time step dt is used for both RBCs and NPs. (B) 
different time steps are used for RBCs (dt) and NPs (dtt) so that the overlapping is 
avoided. (C) Illustration of linear interpolation for RBC’s intermediate positions. 
 
 However, a few problems may arise due to the using of varied time stepping. 
When NPs approach the RBCs, the shortest distance sL between NPs and the RBCs' 
surface is calculated and compared with a cut-off distance cutR defined for 
implementation of Morse potential. For s cutL R< , the Morse potential applies a repulsive 
force so that NPs can be repelled away. However, the particles may penetrate into the 
RBCs if the distance the RBCs travel per time dt is larger than cutR which usually happens 
A B C 
t=t1
t=t1+dt
t=t1+i*dtt
t=t1
t1 t1+dt
ds(t1)
dtt
ds(t1+dt)
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unless a very small flow velocity is applied. To resolve this problem, the time step for 
RBCs dt is divided into a number of equally small time step dtt, as shown in Figure 3C, 
and the RBC position virtual images at intermediate time intervals are interpolated by: 
 
s s
s 1 1
1 1
s ( ) ( )( * ) ( )
d t dt d t
t i dtt d t i dtt
dt
d
+ −
+ = + × ×   (20) 
 Such virtual images for RBCs are established only for cell-particle repulsive force 
calculation. In the simulation, cutR  is 400 nm. If the fluid velocity is 40 µm/s, to avoid 
particle penetration, the maximum time step is chosen to be 0.01s.  However, during 
0.01s, NP travels 296 nm due to Brownian motion. Also due to the exponential form of 
Morse potential and power form of Lennard-Jones potential, if NP jumps with a big 
distance, the repulsive force generated by two potentials will repel NP out of the fluid 
domain. To be safe, dtt is chosen as 0.00001s to make sure NP travels about 9 nm each 
time step. In summary, the position of RBCs is updated based on larger time step dt while 
NPs positions are updated on smaller time step dtt. The collision between the RBCs and 
NPs are captured by RBC virtual images at intermediate steps.  Such two time step 
algorithm will largely increase the simulation speed without losing accuracy.  
3.2 Nanoparticle dispersion coefficient calculation 
 NP dispersion coefficient will be calculated under various flows conditions. The 
dispersion coefficient can be evaluated by tracking the motion of NPs and calculate the 
mean square displacements[64-66]. Since margination process is important in 
nanoparticle attachment to vascular wall and drug delivery, we focus on the particle 
dispersion in the radial direction. The mean square displacement (MSD) is defined as 
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α α
α
ξ τ τ τ
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where ( )ir t
α τ +  is the radial-coordinate of particle α from initial configuration i  at time 
t  starting from τ . N is the total number of particles, cN is the total number of simulation 
runs. τ is chosen to be large enough so that there is no dependence on the initial particle 
distribution. Then the Overall Diffusion Coefficient (ODC) can be obtained by
 
 1( , ) ( , )
2
d
D t t
dt
τ ξ τ= < >   (22) 
 It should be noted that NPs dispersion in blood vessel is not a free diffusion 
process because NPs have instantaneous collisions with the RBCs and vessel wall. In this 
sense, the mean square displacement defined before cannot truly reflect the distance NPs 
traveled at each time step. Thus to better reflect the interaction of RBCs on NP diffusion, 
Instantaneous Diffusion Coefficient (IDC) is defined as 
 2
1 1
1 1
( ) [ ( ) ( )] 2
cN N
i i I
ic
dtt r t dtt r t D dtt
N N
α α
α
ξ
= =
< >= + − =∑ ∑   (23) 
where dtt is the small time step, ID  is the Instantaneous Diffusion Coefficient, 
( )dttξ< > is the Instantaneous Mean Square Displacement (IMSD). 
3.3 Simulation Results 
Since RBCs consist of almost 50% of the blood and are dominant over all other 
blood cells, only RBCs and NPs are modeled in the simulation. The combined Immersed 
Finite Element and particle Brownian dynamics model is used to model the NPs delivery 
process in microcirculation.  
 19 
 The number of RBCs inside the simulation domain is determined by the volume 
ratio of RBC to blood to achieve a RBC concentration close to the hematocrit of human 
blood (normally in the range of 30-55% in larger arteries and drops to 10-15% in 
capillaries[67]). In our simulation, a number of RBCs are put into the fluid domain to 
reach a hematocrit of around 36%.  NP size is chosen between 10~200 nm which is 
recommended in literature[68-70]. NP concentration is around 1 µg/1µL which is 
consistent with cancer targeted PLGA-PEG-COOH NP suspension of 10 ug/uL[71], 
Paclitaxel-loaded TPGS-emulsified PLGA NPs with concentration of 10 mg/mL[72] and 
Antitubercular drugs loaded PLG-NP with concentration of 25mg/2mL[73]. Period 
boundary conditions are applied to the left and right side of boundaries so that RBCs and 
NPs exit from one end of the channel can re-enter the inlet. Based on Einstein–Stokes 
equation, theoretical diffusion coefficient for the NPs with a diameter of 100 nm is 
2.2×10-8 cm2/s. The average flow rate in the channel is 20 µm/s, which is within 
physiological speed range from 10-100 µm /s for capillary vessel with diameter between 
10 and 20 µm[74].  
 In the simulations, two independent sets of meshes are used for RBCs and fluid 
domain. Each Red blood cell consists of 1534 nodes and 4340 elements. The fluid mesh 
has 5705 nodes and 16632 elements. A time step of 0.00001 s and 0.002 s are used for the 
NP Brownian dynamics and RBCs-fluid interaction simulations, respectively.  To clearly 
illustrate both NPs and RBCs, cross-sectional views are used in the simulation snapshots 
throughout this thesis. 
 To explore the effect of RBCs on NP delivery, three sets of simulation setups are 
used: pure particles, particles mixed with RBCs to keep the total amount of particle same 
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as pure particle case, and particles mixed with RBC to keep the same effect concentration 
excluding RBC volume, as shown in Figure 4. The pure particle case is used as a control. 
The second case is used to check the influence of RBCs on particle dispersion and 
binding if the same dosage of NPs is considered. The third case is used to check the 
influence of RBCs on particle dispersion and binding if volume exclusion effect of the 
RBCs is removed, thus the effective particle concentration is the same as the pure particle 
case. Normally NP suspension will increase the effective viscosity of blood. In our work, 
NP volume concentration is about 0.08%, based on the results reported in Lee et.al.[75], 
under such a low concentration, the enhancement of NP on viscosity is less than 1%, thus 
it is reasonable to ignore the viscosity enhancing effect. 
 
Figure 4. Illustration of three different simulation setups: (A) pure particles; (B) same NP 
dosage mixed with RBCs; (C) same effective particle concentration mixed with RBC s. 
A B C 
 21 
3.3.1 Verification of NP diffusion coefficient with Taylor-Aris theory 
 
Figure 5. (A) Taylor-Aris effect for the NP diffusion in vessel. (B) Overall Mean square 
displacement (MSD) for NPs in flow direction, which is a quadratic function of time t; (C) 
Instantaneous Mean Square Displacement (IMSD) for NPs in flow direction, the average 
instantaneous diffusion coefficient is about 2.2×10-8 cm2/s (here dtt=0.01s, which is 
different from NP-RBC simulation case). 
 
 When NPs are injected into the blood flow, they spread out across the vessel 
under the combined effects of diffusion and fluid flow. It is derived analytically that the 
particle concentration generated is centered on a point which moves with the mean speed 
of flow and is symmetrical about this point in spite of the asymmetry of the flow[76], as 
shown in Figure 5. The diffusion coefficient for NPs with a diameter of 100 nm is 
2.2×10-8 cm2/s. By tracking the position of the NPs in fluid flow direction, the diffusion 
can be calculated by MSD: 
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(24) 
where iV
α is the velocity of particle α at time step i , XD is the diffusion in fluid flow 
direction indicated by X.  
 The observed MSD is a quadratic function of t since the displacement contains 
axial displacement term iV t
α , as shown in Figure 5A. To eliminate the tube flow effect on 
NPs distribution, Eqn. (24) is used to obtain the diffusion coefficient in x direction. By 
linear data fitting, average IMSD  ( )dttξ< > =4.38×10-10 cm2, as indicated by a dash line 
in Figure 5B. Thus, the diffusion coefficient is 8 2
( )
2.19 10 /
2X
dtt
D cm s
dtt
ξ −< >= = × , 
which agrees with the theoretical value. 
3.3.2 The influence of shear rate on nanoparticle delivery 
 The influence of different shear rates on nanoparticle delivery is considered first. 
The shear rate is determined by the velocity of the blood flow and vessel diameter. 
Typically in capillary with size between 10 and 20 µm in diameter, the mean velocity of 
blood flow usually ranges from 10 µm/s to 100 µm/s [74], and the maximum shear rate at 
the vessel wall ranges from 8 to 40 s-1.  In the simulation model, the effect of RBC 
tumbling motion on the dispersion of NPs under the shear rate of 8 s-1 and 16 s-1 are 
considered. 10 nm and 100 nm size of NPs are chose to differentiate the size effect since 
both are within the recommended size range (10~200 nm) of tumor drugs. A snap shot of 
the model is shown in Figure 6.  
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Figure 6. Simulation of RBCs and NPs interaction under a shear flow. (A) initial 
configuration of the model; (B) a snap shot of the model at 0.74 s. 
 
 RBC tumbling motion is found to help the dispersion of the NPs from the core 
region toward the edge of the simulation domain, as shown in Figure 6. Once RBCs 
tumble under shear flow, NPs begin to redistribute along with the motion of the RBCs. 
Compare to the case with pure NPs, the NP distribution when mixed with RBCs is not 
uniform, with more NPs in the near vessel wall region. Such non-uniform NP distribution, 
as shown in Figure 7, is favorable for NPs targeted binding and subsequently leads to 
higher NP binding efficacy.  From Figure 7A, it is shown that with RBCs, the number of 
NPs in the edge region increases from 5% to 10%, almost doubled compared to that 
without RBCs. Such non-uniform NP distribution is induced by the RBCs volumetric 
exclusion and tumbling effect. Similar increased near-wall high particle concentration has 
also been reported for platelet distribution in capillary flow[77-80].   
B A 
core 
region 2
0µ
m
 
25µm 
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Figure 7. Nanoparticle distribution profile across the vessel. (A) initial NP distribution 
profile with RBCs; (B) NP distribution profile with RBCs at 1 s; (C) initial NP 
distribution profile without RBCs;  (D) NP distribution profile without RBCs at 1 s. 
 
 Besides distribution, RBCs also influence NPs dispersion. The existence of RBCs 
serves as dual roles to the particle dispersion. On one hand, due to the interaction 
between the cells and the particles, the particles will be pushed around as RBCs tumble in 
the blood, thus lead to higher dispersion coefficient. For example, when 100 nm diameter 
NPs are introduced in the model under a shear rate of 8 s-1, the average dispersion 
coefficient (half of the slope of the mean square displacement) is 3.6×10-8 cm2/s, a 
significant increase compared to the theoretical value of 2.2×10-8 cm2/s without RBCs 
with RBC
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considered, as shown in Figure 8A. Such enhanced dispersion is also observed by Crowl 
et al. [78] on platelet motion induced by red blood cells. On the other hand, RBCs trap 
particles in the space in between, especially for small NPs which diffuse faster than 
RBCs rotation. For example, the trapping effect for 10 nm particles is dominant during 
the first 0.7s when RBCs/NPs mixture are placed under a shear flow; however, the 
diffusion enhancement effect outweighs trapping effect once the RBCs tumbling become 
apparent, which is reflected in Figure 8B where the average dispersion coefficient with 
RBCs is 9.3×10-8 cm2/s as compared to 6.4×10-8 cm2/s without RBCs. It should be noted 
that the dispersion coefficient without RBCs is smaller than the theoretical free diffusion 
value 2.2×10-7 cm2/s due to the constrained effect at the fluid channel boundaries. The 
zoom-in sub-plot of the MSD at the beginning (Figure 8B) shows that the dispersion 
coefficient is close to the theoretical value of free diffusion. To eliminate the constrained 
effect, the instantaneous diffusion coefficients (IDC) is calculated based on Eqn.(23). It is 
shown in Figure 8C that IDCs are very close to the theoretical value of NPs of 
corresponding size. For example, for 100 nm NPs, the IDC with RBCs is 2.22×10-8 cm2/s, 
while the IDC without RBCs is 2.20×10-8 cm2/s, as shown in Figure 8C. Similar results 
were also observed for 10 nm NPs, as shown in Figure 8D. 
 26 
  
Figure 8.The overall mean square displacements (MSD) of the particles with RBCs and 
without RBCs under a shear rate of 8 s-1, which show that RBCs enhance the dispersion 
for both larger NPs and smaller NPs, but in slightly different ways. (A) NPs with size of 
100 nm;  (B) NPs with size of 10 nm, the zoom-in subplot show smaller NPs are trapped 
initially by RBCs. Instantaneous mean square displacement (IMSD) of the particles with 
RBCs and without RBCs under shear rate of 8 s-1: (C) NPs with size of 100 nm;  (D) NPs 
with size of 10 nm. 
 
 The diffusion coefficient of particles is a physical property which usually should 
not change with shear rates. However, the dispersion rate might be influenced by the 
existence of RBCs and change with shear rates. The dispersion rate of NPs is 
characterized at different shear rates in our simulations. With RBCs, as the shear rate 
increases, the mean square displacement for NPs increases for both 100 nm and 10 nm 
diameter NPs, as shown in Figure 9. This is explained by the fact that RBCs tumbles 
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faster at higher shear rates, thus push the surrounding NPs and lead to larger dispersion. 
The enhancement in dispersion rate due to the existence of RBCs is more apparent for 
100 nm NPs compared to 10 nm NPs.  However, without RBCs, no matter how much the 
shear rate increases, the dispersion coefficients for NPs almost keep un-changed. Thus, 
larger shear rate enhances NPs dispersion due to the faster rotation of RBCs, which is 
favorable for NPs margination toward vessel wall surface.   
 
Figure 9. Mean square displacement of NPs under shear rates of 8 s-1 and 16 s-1 with 
RBCs and without RBCs. (A) 100 nm size of NPs; (B) 10 nm size of NPs. 
 
3.3.3 The influence of RBCs on NP binding 
 NP binding dynamics involves molecular level binding between ligands coated on 
the NP surface and receptors on the vessel wall. The detailed binding adhesion dynamics 
of individual particles of arbitrary shape under various flow conditions has been studied 
in our previous work[81]. In this thesis, we focus on collective behavior of NPs under the 
influence of RBCs, thus simply bind NPs upon its contact with the wall surface. As 
described in Section B, the existence of RBCs lead to high near-wall NP concentration 
and is expected to induce faster NP binding. The NP binding dynamics is studied in a 20 
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µm wide vessel with the existence of RBCs under an average inlet flow rate of 20 µm/s. 
With RBCs, the particle distribution is not uniform (see Figure 10A and B), particularly 
with more particles in the near vessel wall region. This non-uniform particle distribution 
is favorable for NPs targeted binding because with high concentration in the cell free 
layer region, more particles are likely to bind to the diseased area. 
   
Figure 10. Particle distribution profile at time t=7.5s. (A) NPs with RBCs case; (B) NPs 
without RBCs. 
 
 The NPs binding time history is plotted in Figure 11. For the same NP 
concentration case, there are fewer NPs in the simulation domain, thus the total number 
of bounded NPs with the existence of RBCs is less than that without RBCs. However, the 
NPs binding rate in the initial stage with the existence of RBCs is higher than that 
without RBCs, as shown in Figure 11A. For the same NP dosage case, since the NP 
density at the near wall region is much higher than that without RBCs, NPs with RBCs 
bind at a significantly higher rate than that without RBCs, as shown in Figure 11B. In 
Figure 11, the number of bonded NPs gradually reaches a plateau, which indicates that 
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NP binding is a diffusion limited reaction process and the number of free NPs decreases 
over time. 
 
Figure 11. (A) Nanoparticle binding time histories with and without RBCs of the same 
effective nanoparticle density; (B) Nanoparticle binding time histories with and without 
RBCs of the same NP dosage. 
 
 For quantitative calculation of the binding rate, a first order reaction model is used 
to fit the binding curve to retrieve the binding rate: 
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 where bN is the number of bonds, 0N is the total number of NPs in the fluid 
domain, fK  is the forward binding rate with units of 1/s. 
 The analytical solution for Eqn.(25) is 0 (1 exp( ))b fN N K t= − −  
 However, if the bonds formation is diffusion or reaction limited, the kinematics of 
bonds formation is not exponential function of time. Douglas et al.[82] proposed to use a 
non-exponential reaction rate to express the bonds formation, which can be modified as: 
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 0 (1 exp[ ( ) ])b fN N K t
β= − −  where β is a parameter related to the time dependent 
rate. 
 The same method is also used by Park et al.[83] to fit the data of non-equilibrium 
NP adsorption on a model biological substrate. By fitting the data obtained in NPs 
binding time history, the binding rates with RBCs, without RBCs, under the same density, 
and under the same dosage are summarized in Figure 12. 
 
Figure 12. NPs binding rates with RBCs and without RBCs under same density and same 
dosage. Such increased binding rate is explained by the higher NP concentration in the 
cell-free-layer and larger dispersion rate. 
 
 As shown in Figure 10, with RBCs, the percentage of particles in the cell free 
layer increase from 5% to 10%, almost doubled compared to that without RBCs. This 
favorable particle distribution leads to more than two times higher binding efficacy for 
NPs with RBCs compared to that without RBCs, as shown in Figure 12. This higher 
binding rate is likely to be induced by the tumbling and blocking effect of RBCs which 
can help increase the NP density in the cell free layer. The particles enter the cell free 
layer cannot easily diffuse back to the core region of the vessel filled with RBCs. While 
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without RBCs, the particles are free to diffuse in any direction, thus, the binding rate 
decreases. 
3.4  Microfluidic experimental validation 
 Microfluidic based blood vessel mimicking devices have been successfully 
developed in our lab to study NP transport and distribution[84]. To verify the results 
obtained in the simulation, experimental study on NPs distribution was performed by 
flowing 100 nm fluorescence NPs through a microfluidic channel of width 20 µm. In 
brief, straight 20 µm wide microfluidic channels were fabricated using standard soft 
lithography process[85]. The PDMS microfluidic device was bonded on clean glass slides 
after treating in an oxygen plasma chamber. The surface of the PDMS device was then 
functionalized with NeutrAvidin to bind with the biotin coated NPs. A mixture of RBCs 
and 100 nm biotin coated NPs with volume ratio of 36% was injected into the 
microfluidic device using a Harvard PHD 2000 syringe pump. The same flow rate used 
the simulation was chosen (20 µm/s). Channels were flushed with Phosphate Buffered 
Saline to remove unbound NPs from the channel after NPs distribution reached 
equilibrium. Imaging was done using a fluorescent microscope (Olympus IX81). After 
eliminating the background noise and normalizing the fluorescence intensity with the 
total intensity, the fluorescence intensity distribution of NPs across the channel is 
analyzed and plotted in Figure 13A. It is observed that the NP fluorescent intensity is 
higher near the channel wall compared to the core region, which is consistent with the 
simulated NPs distribution profile shown in Figure 13B. As a control case, flux of pure 
NPs without RBCs was also performed, as shown in Figure 13C. The NP fluorescent 
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intensity profile is flat across the channel, which again agrees with the simulation results 
shown in Figure 13D. It should be noted that NP fluorescent intensity is not exactly NP 
concentration. Due to the small size of the NPs and high flow rate, individual NPs are 
very hard to be visualized even with high-speed spinning disk confocal microscope. 
However, it is believed that NP fluorescence intensity profile essentially reflect the 
characteristics of the NPs distribution. Comparing the simulation and experiment data, it 
is concluded that RBCs can enhance the NP concentration in the margin of the vessels, 
thus leads to higher binding rate. 
 
Figure 13. Fluorescence intensity across the channel in microfluidic tests, the error bar is 
plotted based on 10 runs of tests: (A) with RBCs; (C) without RBCs; (B) and (D): 
simulated NP distribution across the channel in the simulation with and without RBCs 
from Figure 10. 
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Chapter 4. Nanoparticle distribution in a vascular network 
Blood vascular network consists of many generations of vessels with decreasing 
diameter from parents to daughters. Besides diameter, the angle between two daughters at 
the branch varies, which leads to different hydrodynamic conditions at each vessel trees. 
The angle of the bifurcation depends on the relative diameter of the daughter vessels[86]. 
In our model, the fluid domain contains one parent channel and two daughter channels. 
Both the parent and daughters are modeled as cylinders with constant diameters: 2 µm for 
parent channel and 1 µm for daughter channel. These small diameters are chosen because 
of the nanometer size of the nanoparticles which makes modeling in bigger channels 
computational very expensive. The characteristics of the NP distribution are mainly 
influenced by local shear rates, rather than channel diameter. Branched angle (defined as 
the angle between the center line of the parent vessel and the center line of the daughter) 
is chosen to be 45 degree. Due to cylindrical symmetry, the longitudinal cross section is 
shown in Figure 14. A rectangular region with length 3 µm and a circular region with 
diameter 2 µm are chosen as the representative of the straight region and branched region, 
respectively, as shown in the Figure 14B. The walls are set to be non-slip boundaries, the 
inlet is applied with a fluid velocity and the outlets are open. 
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Figure 14. A bifurcation microchannel for NP deposition simulation. (A) geometry 
dimensions; (B) illustration of straight section and bifurcation area. 
4.1 Shape dependent Nanoparticle binding dynamics 
 
Figure 15. Trajectory snapshots of a nanosphere (A) and a nanorod (B) under shear flow. 
The arrows illustrate the adhesive force once the particles interact with the wall. 
 
 Under a shear flow, spheres and rods exhibit different binding behaviors. The 
particle shape influences both initiation of adhesion and sustained binding after adhesion. 
First, initial contacts between NP and surface depend on particle shape. For 
spheres, their contact area is orientation irrelevant with a constant binding area; For rods, 
while they might have higher chance of initiating contact due to larger length and 
tumbling motion, rod binding is orientation dependent with varying contact area, as 
shown in Figure 15. Under a low shear rate, it is expected that both spheres and rods bind 
immediately as they contact the wall because adhesion force of a single bond is bigger 
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than the drag under low shear rate. At medium shear rate, the transitional contact/bind of 
nanorod is not enough to hold the particle and might get washed away easier compared to 
nanosphere. At high shear rate, the bonding force of spheres can't resist the drag force 
and will get washed away. In contrast, rods have a larger contact area and reduced drag 
force when the principle long axis is aligned with the wall, thus has higher resistance and 
larger adhesion probability at high shear rate.  
Second, the NP shape also influences the probability of NP to stay adhered or 
being washed away after initial adhesion. Decuzzi et al. studied the adhesive strength of 
non-spherical particles under shear flow[28].  Assuming the particle is fixed along the 
surface, the attaching probability can be expressed as, 
 
0
exp[ ]a disc
r l a B r c
P F
A
m m K k T m A
λ
= −   (26) 
 where 0aK  is the association constant at zero load of the ligand-receptor pair; disF  
is the dislodging force due to hydrodynamic forces; mr, and ml are the receptor and ligand 
density respectively; Ac is contact area; λ is the characteristic length of the ligand-receptor 
bonds; kB is the Boltzmann constant; and T is the temperature. From Eqn.(26), the 
normalized binding probability is plotted in Figure 16 with a hypothesis of 100% binding 
at shear rate of zero at the centroid of NPs. As shown in Figure 16, higher aspect ratio rod 
(γ=5) has the largest binding probability while sphere has the least binding probability. 
The difference becomes larger as NP size increases from 100 nm to 200 nm. It should be 
noted that the binding probability is based on the assumption that the long axis of 
nanorod is aligned with the binding surface, thus describes an equilibrium state rather 
than transitional state.  
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Figure 16. Normalized binding probability for (A) NP size of 100 nm; (B) NP size of 200 
nm. 
4.2 Distribution of Nanoparticles of different sizes 
 As shown in Figure 17, the deposition of particles at the bifurcation is influenced 
by their size. For 200 nm particles, the deposition pattern are more scattered due to the 
large shear force exerted by the fluid. However, for 100 nm particles, once the receptor-
ligand bonds are initiated upon contact, most likely they will bind there with much less 
rolling, which leads to a compact binding pattern. Also, 100 nm NPs diffuse speed is 
about 2  times faster than 200 nm particles. So it takes more time for 200 nm NPs to 
bind at the wall. With the same fluid flow, the binding sites of 200 nm NPs are further 
than 100 nm NPs from the inlet of the channel, as indicated by the difference of starting 
binding sites in Figure 17. 
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Figure 17. Distribution of nanospheres of different sizes. Half of the channel is shown in 
the figure due to symmetry. Top: 100 nm; Bottom: 200 nm. 
 
4.3 Distribution of nanoparticles of different shapes and size under 
various shear rates 
The shear rate at the vascular wall usually ranges from 250 s-1 to 2000 s-1 at 
capillaries[87]. To study the NP distribution under different flow conditions, simulations 
are performed for shear rates at the wall in the straight section of 100 s-1, 200 s-1, 400 s-1, 
600 s-1, and 1000 s-1, respectively.   For convenience, flow rate at the inlet is used in some 
parts of the description since the shear rate varies at different locations of the branched 
channel. 
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Figure 18. A snap shot of the particle distribution in the branched vessel for (A) spheres; 
(B)rods. 
 
At the inlet of the vessel, 200 NPs of spheres and rods are released at the core 
region of the vessel, respectively. The distribution of NPs is recorded after one flow flush. 
Two snapshots of the NP distribution are shown in Figure 18. The binding density of 100 
nm NPs over the whole channel is shown in Figure 19. There are several interesting 
observations in NP distribution.  
First, a significant increase of particles density happens at about 6 µm distance 
from the inlet where the bifurcation begins. Such higher binding density at branched 
region applies to all cases simulated except for the sphere at the highest flow rate of 500 
µm/s, which has 1000 s-1 shear rate at straight channel and 2000 s-1 shear rate at branched 
region, as shown in Figure 19E. The flow is deviated at the bifurcation point, which leads 
to a higher opportunity for NP to initiate contact with the channel wall. Figure 19E 
implies that the bonding force for spheres cannot resist the drag force from the blood at 
such high shear rate. The shear rate at the bifurcation is as high as 2000 s-1, which 
corresponds to an adhesion probability of around 15%, as shown in Figure 16A.  
A B 
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 Second, NP binding rate decreases as shear rate increases. This is indicated by the 
decrease of the total number of bonded particles along the fluid channel from Figure A to 
E. Higher shear rate increases the drag force exerted on the NP, thus leading to low 
binding. This observation is consistent with theoretical prediction shown in Figure 16 and 
other experimental observations [88-89].  
Third, high aspect ratio rod shows higher binding density at low shear rates 
(Figure A-C), and lower binding density at higher shear rates (Figure 19D-E). This is 
quite counterintuitive and different from the theoretical prediction shown in Figure 16. 
This might be induced by the competence between drag force and bonding force. At low 
shear rate, the binding force from a few ligand-receptor bonds is large enough to hold the 
particles. Nanorod has higher chance of contact with the wall, thus higher binding. 
However, in high shear rate, the drag force exerted on the NPs depends on the orientation 
of the NPs. For example, if a rod has a point contact with the wall, it is subjected to a 
larger drag and smaller adhesion force, and gets drifting away easily. If it is in contact the 
wall aligned with its long axis, it may stay bonded with the wall due to the larger 
adhesion force and smaller drag force. This concept is clearly illustrated in Figure 20 
through the snap shots of a sphere and a rod during the dynamics binding process.  
Another interesting observation is the dynamic shifting in distribution of NPs at 
different shear rates. As the flow rate increases, the particle binding distribution tends to 
shift toward downstream, as indicated by the dash dark lines marking the peak of 
distribution. More particles are bonded in the downstream, e.g., the particle density at 8 
µm changes from 0 at 50 µm/s to 4 at 300 µm/s. At high shear rates, NP cannot bind 
firmly upon contact with the wall. Due to the tethering effect of receptor-ligand bonds, 
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NP keeps rolling and tumbling along the surface until the adhesion force outweighs the 
drag force. Although some NPs will bind in the end, the final binding sites are different 
from their initial contact sites.  
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Figure 19. 100 nm nanoparticle distribution along the channel .(A)50 µm /s, (B)100 µm 
/s,(C) 200 µm /s,(D) 300 µm /s,(E) 500 µm /s. 
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Figure 20. Adhesion of NPs depends on particle shape and their orientation. Nanorods 
have smaller contact area and bonding force during transient rotation, but maximal 
bonding force after laying down with long axis aligned with wall . 
 
NPs of 200 nm are also simulated to study how NP size changes its distribution. 
The distributions of 200 nm NPs over different shear rates are shown in Figure 21. 
Compared to 100 nm case shown in Figure 19, the total number of bonded NPs decreases 
with increased size. At low shear rate, the NPs distribution is more non-uniform for 200 
nm NPs compared to 100 nm NPs, with more NPs deposited at the bifurcation region.  At 
the shear rate increases, the detachment of particles begins to happen at the bifurcation 
region. For example, detachment of spheres begins to happen at 200 µm/s, which is lower 
than the 100 nm case. This is because larger NPs experience larger drag force at the same 
shear rate, thus are easier to be detached. At the high flow rate of 300 µm/s, most spheres 
are unable to bind. At the highest flow rate of 500 µm/s, only rods with high aspect ratio 
of 5 are able to bind onto the wall. The binding density for both nanorod and nanosphere 
decreases over increased flow rate. 
shear flow 
sphere rod γ=3 rod γ=5 
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Figure 21. 200 nm Nanoparticle distribution along the channel .(A)50 µm/s, (B)100 µm/s, 
(C) 200 µm/s,(D) 300 µm/s,(E) 500 µm/s. 
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4.4 Influence of Péclet number on Nanoparticle distribution pattern 
While adhesion plays an important role in NP binding after contact, the 
initialization of NP contact with wall is mainly determined by convection and diffusion.  
The fraction of NPs deposited on the straight section and the branched region is 
influenced by flow rate, NP diffusion speed and channel size, which could be 
characterized by the Péclet number (Pe) defined as: 
 LUPe
D
=  (27) 
where L is the characteristic length of the channel, U is the average fluid velocity, and D 
is the NP diffusion coefficient. In our model, L is chosen as 1 µm, D is calculated from 
Stokes-Einstein equation as 4.4×10-12 m2/s and 2.2×10-12 m2/s for 100 nm and 200 nm 
NPs, respectively. 
To characterize the NP distribution, the ratio between the number of deposited 
NPs in branched region and straight section is plotted as a function of Péclet number. As 
shown in Figure 22. When Péclet number is small, diffusion is dominant so that most 
NPs bind at the straight section. As the Péclet number increases, convection becomes 
dominant, leading to higher binding density at the branched region.  However, the ratio 
reaches peak first and then decreases as Péclet number increases. This is because higher 
Péclet number means higher flow speed, which makes NP difficult to marginate toward 
wall. Shape also influences the distribution ratio. Spheres reach the peak ratio at the 
smallest Péclet number, followed by rod-shaped NPs with aspect ratio γ=3, while NPs 
with aspect ratio γ=5 have the peak ratio latest.   
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Figure 22. Ratio of the number of deposited NPs on branched region and straight section 
depends on the Péclet number. The simulation data are fitted by quadratic lines through 
least square method. (A) 100 nm NPs; (B) 200 nm NPs. 
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Chapter 5. Conclusion and Future work 
In summary, a particle-cell hybrid model is developed to model nanoparticles 
transport, dispersion, and adhesion in blood stream through coupled Immersed Finite 
Element method and particle Brownian adhesion dynamics. The dispersion and adhesion 
kinetics of NPs in microcirculation is studied for the first time with cell hydrodynamics 
coupled with particle Brownian dynamics. The adhesion kinetics of NPs is found to be 
significantly influenced by the existence of RBCs and shear rates. The cell-free-layer and 
NP-cell interaction largely influence both the dispersion and binding rates, thus impact 
targeted delivery efficacy. Under a shear flow, the RBCs' tumbling motion will enhance 
NP dispersion. NP dispersion rate increases with shear rate. The distribution of NPs in 
capillary flow is not uniform, with more particles near the vessel wall surface. Such 
margination of NPs occurs due to hydrodynamic interaction rather than RBCs volumetric 
exclusion effect. Higher density of NPs in the near-wall region leads to higher binding 
rate for NPs in 20 µm capillaries. The binding rate of NPs with RBCs is two times of that 
without RBCs. This observation is applicable to NPs of various sizes from 10 nm to 200 
nm.   
From the branched vessels model, it is observed that NPs with smaller size bind 
fast than bigger ones. This is because diffusion coefficient is proportional to the inverse 
of particle size, thus diffusion speed for 100 nm particles is 2  times faster than 200 nm 
particles. Meanwhile, larger particles are subjected to larger drag force from fluid flow, 
which lead to lower binding probability. This conclusion is consistent with the statement 
that the critical shear stress required to remove adhered particles decreases as particles 
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size increases[90]. The binding dynamics of rod-shaped NPs is initial contact and 
orientation dependent. Rod shaped NPs with larger aspect ratio do not necessarily have 
higher binding rate. This observation is quite different from the prediction from 
theoretical model[28]. One assumption made in the theoretical model is that the long axis 
of non-spherical particles is aligned with the contact wall, which ensures the largest 
adhesion force with maximal contact area. However, such idealized binding configuration 
does not always occur in vivo. Such counter-intuitive finding is consistent with other 
group's simulation results which state that the interaction between NPs and cells is 
particle initial contact orientation and local curvature dependent at the contact site[91]. 
Moreover, NP bond formation depends on the balance between adhesion and drag force. 
The drag force increases linearly with shear rate resulting in lower binding probability of 
NPs at higher shear rate. The diverging flow at vessel bifurcations enables particles to 
have larger binding propensity. Furthermore, the percentage of NPs binding to the 
straight section and bifurcation region is found to be a function of Péclet number. When 
Péclet number is small, diffusion is dominant, thus more particles are deposited at the 
straight section. As Péclet number increases, convection dominates over diffusion so that 
more particles are transported and deposited to the bifurcation region. For even larger 
Péclet number, the shear stress at the wall surpasses the critical shear stress for stable NP 
binding, leading to detachment of NPs. Results from this study contribute to the 
fundamental understanding and knowledge on how the particulate nature of blood 
influences NP delivery, which will provide mechanistic insights on the nanomedicine 
design for targeted drug delivery applications. 
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 It should be noted that in our model, the particle distribution is studied at 
microscale where motion of individual particle is tracked and the binding dynamics is 
described with details of ligand-receptor bonds. However, to predict large scale overall in 
vivo distribution, a higher scale continuum model is required to characterize NP 
convection, diffusion and reaction. In the continuum model, particle binding will be 
described in terms of NP concentration, diffusion coefficient, shear rates, reaction rates, 
etc. How to link the microscale particulate model with the continuum model will be an 
interesting topic to explore in the future. A multiscale model consisting of continuum 
model of organ level and particulate model of cellular level will be beneficial to NP 
distribution prediction and drug dosage administration. It is very important to develop a 
personalized drug delivery prediction tool. Both doctors and patients will be happy if they 
know where the drug goes and the minimal drug dosage to fight against the disease 
beforehand. For example, based on the magnetic resonance imaging (MRI) of a patient, 
an organ level of vasculature network can be reconstructed and input into computational 
model. Specific physiological conditions can be applied to the model to accurately 
simulate the drug transport. Mathematical modeling of drug delivery in patient specific 
coronary artery walls has been done by J.R. Hughes[92].  
However, the large scale model will present more challenges to the researchers. 
Nowadays, super computers can handle the whole model with many generations of 
vessels, blood components, and drugs. Millions of elements can be loaded and processed 
by fast computers. The bottleneck is how to develop an algorithm that scales well on 
millions of heterogeneous cores. Some pioneering works have been done to face this 
grand challenge. For example, Dr. Margetts did a lot of work in parallel finite element 
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analysis[93], particularly in solving Navier-Stokes equations. Fast algorithms for 
simulating the dynamics of vesicles suspended in 3D flow has been studied recently[94] 
and can be extended to model RBCs, platelets, and particles in large scale blood flow.  
 Based on aforementioned discussion, the future work based on this thesis is listed 
below: 
 1) Create a multiscale model that can link the nanoscale NP reaction model to 
continuum scale model. We hope we can obtain continuum scale parameters such as 
adhesion and detaching rates directly from the nanoscale model. 
 2) Extend the current code into a parallel one, which requires to design the 
algorithm from the parallelization point of view. Specifically, it has several capabilities: 
first, it can make the code run faster with a full use of the currently available computing 
resources; second, it will enable us to model large scale drug delivery in vascular 
geometry based on scanned MRI images, since fast algorithm can handle more complex 
and challenge computing within a reasonable time. 
 3) Verify and validate the simulation results through microfluidic experiments in 
mimetic blood vessels. The mathematical tool for NP binding and distribution prediction 
will be more meaningful if the control experiments can validate the computational results. 
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